Found 20 matching trials
Can Additional Drug Therapy Accelerate Response Time to Antidepressants
PHASE4Antidepressants are commonly prescribed and are effective for treating depr...
Location
UCLA Neuropsychiatric Institute
Psilocybin Administration With 5-HT1a Blockade
EARLY_PHASE1The purpose of this study is to assess the effects of 5-HT1A receptor block...
Location
Center for Psychedelics and Consciousness Research
Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand Preparations
PHASE1Generic describes a pharmaceutical product that does not have a brand name ...
Location
University of Ottawa, Institute of Mental Health Research
Coreg and HSRs-Updated Analysis
N/AA cluster of reports of hypersensitivity reactions among patients who switc...
Location
Multiple Locations
Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV)
PHASE1The aim of this early phase two-part study was to compare the bioavailabili...
Location
Quotient Sciences Ltd
N-of-1 for Beta-Blockers in Cardiac Amyloidosis
PHASE4The study team will generate preliminary data on whether patients with card...
Location
Weill Cornell Medicine
A Preliminary Study for INFORMED
PHASE4Investigators will determine whether N-of-1 trials, as a pragmatic, partici...
Location
Weill Cornell Medicine
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
PHASE4In this study, we will test the feasibility of N-of-1 trials for deprescrib...
Location
Weill Cornell Medicine
Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism
PHASE4Reduction of volume of the hippocampus has been associated with major depre...
Location
University of Ottawa Institute of Mental Health Research
EScitalopram PIndolol ONset of Action
PHASE2The main purpose of this study is to determine whether the antidepressant r...
Location
Centre de Thérapies Breves (CTB), Secteur Jonction